arrow
R

Ranjana H. Advani

Stanford Cancer Institute
H指数:100
被引数:4.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hodgkin Lymphoma, Version 1.2026

霍奇金淋巴瘤,版本1.2026

2026-02-011
PRE
Treatment kinetics and local response during and after bridging radiotherapy prior to CAR-T cell therapy for lymphomas

淋巴瘤患者接受桥接放疗前CAR-T细胞治疗期间的局部反应和治疗动力学

2025-12-010
PRE
Functional genomics and tumor microenvironment analysis reveal prognostic biological subtypes in Mantle cell lymphoma

功能基因组学和肿瘤微环境分析揭示了套细胞淋巴瘤中的预后生物学亚型

2025-11-050
OA
B-Cell Lymphomas 3.2025 Featured Updates to the NCCN Guidelines

B细胞淋巴瘤 3.2025 NCCN指南特色更新

2025-10-010
PRE
Association of PET4 Response With Outcomes of BV-CHP vs CHOP in the ECHELON-2 Trial in CD30+ Peripheral T-cell Lymphoma

PET4反应与ECHELON-2试验中CD30+外周T细胞淋巴瘤患者接受BV-CHP vs CHOP治疗的结局相关性研究

2025-08-210
OAAI
Camidanlumab Tesirine in Relapsed or Refractory Classic Hodgkin Lymphoma: A Phase 2 Study

Camidanlumab Tesirine 在复发或难治性经典型霍奇金淋巴瘤中的应用:一项 II 期研究

2025-08-190
OAAI
Brentuximab vedotin plus chemotherapy for the treatment of front-line systemic anaplastic large cell lymphoma: subgroup analysis of the ECHELON-2 study at 5 years’ follow-up

brentuximab vedotin联合化疗用于一线系统性间变性大细胞淋巴瘤的治疗:ECHELON-2研究5年随访的亚组分析

2025-08-010
OAAI
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemia

利妥昔单抗单药治疗既往治疗过的华氏巨球蛋白血症患者长期随访研究

2025-07-210
OAAI
Report of Consensus Panel 3 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with high-risk disease

第十二届华氏巨球蛋白血症国际研讨会第三共识小组关于高风险疾病患者管理的报告

2025-04-080
PRE
Report of Consensus Panel 6 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on Diagnosis and Management of Transformed Waldenstrom's Macroglobulinemia

第十二届华氏巨球蛋白血症国际研讨会第六共识专家组关于转化型华氏巨球蛋白血症的诊断与管理的报告

2025-04-080
PRE
Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: a real-world analysis from 21 US centers
2024-11-141
OAAI
Comprehensive Characterization of the Cell States and Ecosystems in Classic Hodgkin Lymphoma Using Single-Cell RNA-Seq, Digital Deconvolution, and Machine Learning

利用单细胞RNA测序、数字去卷积和机器学习对经典霍奇金淋巴瘤的细胞状态和生态系统进行全面表征

BLOOD
IF23.1
2024-11-050
PRE
Pembrolizumab for Front-Line Treatment of Extranodal NK/T-Cell Lymphoma

帕博利珠单抗一线治疗结外NK/T细胞淋巴瘤

BLOOD
IF23.1
2024-11-050
PRE
Clinical Practice Recommendations for Hematopoietic Cell Transplantation and Cellular Therapies in Follicular Lymphoma: A Collaborative Effort on Behalf of the American Society for Transplantation and Cellular Therapy and the European Society for Blood and Marrow Transplantation

滤泡性淋巴瘤的造血细胞移植和细胞治疗的临床实践建议: 代表美国移植和细胞治疗学会和欧洲血液和骨髓移植学会的合作努力

2024-09-012
OAAI
Phase 2 trial of the farnesyltransferase inhibitor tipifarnib for relapsed/refractory peripheral T-cell lymphoma
2024-08-302
OAAI